This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Universitè Catholique De Louvain, Other. Active years: 2004-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2004-2019
Title: Cedric Hermans: Innovator in Peroxisome-Associated Polypeptides
Introduction
Cedric Hermans is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of lung injuries and oxidative stress-related disorders. His innovative work has the potential to impact medical diagnostics and treatments.
Latest Patents
Cedric Hermans holds a patent for "Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders." This invention relates to an isolated and purified peroxisome-associated polypeptide. It also encompasses the nucleotide sequence encoding the amino sequence, the inhibitor directed against these sequences, and their applications in the diagnosis, treatment, and prevention of lung injuries or diseases.
Career Highlights
Throughout his career, Cedric has focused on advancing the understanding of peroxisome-associated polypeptides. His research has led to the development of innovative solutions for addressing critical health issues related to lung function and oxidative stress.
Collaborations
Cedric has collaborated with esteemed colleagues such as Bernard Knoops and Alfred Bernard. These partnerships have fostered a collaborative environment that enhances the research and development of his innovative ideas.
Conclusion
Cedric Hermans is a pioneering inventor whose work in peroxisome-associated polypeptides holds promise for improving the diagnosis and treatment of lung-related disorders. His contributions to biotechnology are noteworthy and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile